
Name
AT-101
Alternate Names
AT 101
AT101
Abbreviations
None
Category
Chemotherapy
Subcategory
Cytostatic agent--apoptosis inducer
NSC Number
None
Primary Site
Small cell lung cancer
Histology
None
Remarks
Phase II SCLC 2007 Pan-Bcl-2 inhibitor; induces apoptosis. Ascenta Therapeutics.
Coding
This drug should be coded
